Natural-product trials in memory disorders show mixed and uncertain results
A review describes possible cognitive benefits from some compounds, alongside limited effects and unresolved safety questions.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review describes possible cognitive benefits from several natural compounds, but results varied by compound and study design. Curcumin and Melissa officinalis had limited effects, while resveratrol produced mixed findings and some side effects. The abstract does not establish which products meaningfully help people with Alzheimer's disease or mild cognitive impairment.
The studies differed substantially in design and quality. The abstract provides no effect sizes, cognitive test results, or comparator details, so it cannot establish the magnitude or practical importance of any benefit.
What was reviewed
The included trials examined herbal extracts and other natural compounds in people already experiencing cognitive impairment. Herbal extracts were a prominent research category, but their frequency in the literature does not demonstrate greater effectiveness.
Why individual results matter
Some compounds were described as potentially beneficial, including matcha for cognition and sleep. Those tentative descriptions sit alongside limited or mixed findings, so the review cannot support treating all natural products as interchangeable.
The original publication
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Bayo Jimenez MT, Rivas-García L, Sánchez-González C et al.
Int J Mol Sci · 2025
- PubMed ID
- 41226670
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.